Physician

David Michael Dspain, D.O.

According to 2025 Medicare claims, David Dspain, D.O. (NPI: 1093918617) practices medical oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Parker, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 76086-5713. Dspain is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645) and UT Southwestern Accountable Care Network (ACO ID: D0211), participating under both the MSSP and REACH models.

Dspain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 673 traditional Medicare patients, billed 262,818 HCPCS/CPT codes, and received $4,665,177 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,871 prescription claims across 300 beneficiaries totaling $5,681,224 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 24 claims. Open Payments data shows 31 records totaling $641. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,150,877 to $5,681,224. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $17,549 to $3,515.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	800	319,268	$3,744,847
2016	873	329,149	$4,532,610
2017	897	235,658	$4,121,840
2018	999	256,818	$4,071,764
2019	942	274,282	$3,762,362
2020	922	332,309	$4,604,991
2021	851	287,724	$4,656,396
2022	922	224,362	$3,334,640
2023	717	312,508	$4,407,192
2024	673	262,818	$4,665,177

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	236	1,364	$1,150,877
2016	246	1,438	$2,008,250
2017	224	1,407	$2,861,589
2018	243	1,497	$2,480,837
2019	247	1,368	$2,237,835
2020	216	1,315	$2,545,791
2021	250	1,448	$3,470,667
2022	282	1,496	$4,561,916
2023	304	1,681	$4,491,225
2024	300	1,871	$5,681,224

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	209	$32,304
2016	38	234	$29,045
2017	N/R	N/R	N/R
2018	N/R	17	$4,137
2019	N/R	37	$5,422
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$470
2023	N/R	33	$6,376
2024	N/R	24	$1,883

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	261	649	$92
80053	Blood test, comprehensive group of blood chemicals	331	797	$10
36415	Insertion of needle into vein for collection of blood sample	404	1,206	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	385	1,078	$8
83615	Lactate dehydrogenase (enzyme) level	264	561	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	67	2,010	$1,003,881
Revlimid	Lenalidomide	46	1,274	$699,246
Lenalidomide	Lenalidomide	31	868	$447,421
Cabometyx	Cabozantinib S-Malate	21	630	$431,253
Xtandi	Enzalutamide	29	870	$379,011

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$1,442
K0738	Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$441

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$641	SERVIER PHARMACEUTICALS LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Michael Dspain, D.O.?

Tedicare shows public-source Medicare data for David Michael Dspain, D.O. (NPI 1093918617), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Michael Dspain, D.O. have ACO affiliation data?

David Michael Dspain, D.O. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645) and UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to David Michael Dspain, D.O.?

David Michael Dspain, D.O. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does David Michael Dspain, D.O. have Open Payments data?

David Michael Dspain, D.O. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.